Skip to main content
. Author manuscript; available in PMC: 2015 Dec 16.
Published in final edited form as: Cancer Immunol Res. 2015 Mar 13;3(5):567–574. doi: 10.1158/2326-6066.CIR-14-0188

Table 4.

Contingency table for best response to treatment

Factor Best response status
Total
SD PD
Polymorphism
 FF 5 8 13
 FV or VV 8 10 18
 Total 13 18 31
HPV
 Negative 2 4 6
 Positive 3 3 6
 Total 5 7 12
ADCC induciblea
 No 3 11 14
 Yes 6 2 8 (P = 0.01)
 Total 9 13 22

NOTE: No association was observed between best response (RR), FcγRIIIa genotype, and HPV status (both exact and two-sided P values are 1.0).

a

However, there was a better chance of having SD (stable disease response) versus disease progression (PD) for those patients who were ADCC inducible (P = 0.01, exact and two-sided).